Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Clifton

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Blood|November 14, 2022
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenograftsDeyi Zhang, Hailey M Harris, Jonathan Chen, et al.
Plos One|February 6, 2013
Combining functional and structural genomics to sample the essential Burkholderia structomeLoren Baugh, Larry A Gallagher, Rapatbhorn Patrapuvich, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell MalignanciesDaniel W Robbins, Mark A Noviski, Ying Siow Tan, et al.
Tuberculosis (Edinburgh, Scotland)|January 24, 2015
Increasing the structural coverage of tuberculosis drug targetsLoren Baugh, Isabelle Phan, Darren W Begley, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Cell Chemical Biology|March 2, 2023
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapySimone Bonazzi, Eva d'Hennezel, Rohan E J Beckwith, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Blood|November 14, 2022
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenograftsDeyi Zhang, Hailey M Harris, Jonathan Chen, et al.
Plos One|February 6, 2013
Combining functional and structural genomics to sample the essential Burkholderia structomeLoren Baugh, Larry A Gallagher, Rapatbhorn Patrapuvich, et al.
Journal of Medicinal Chemistry|February 1, 2024
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell MalignanciesDaniel W Robbins, Mark A Noviski, Ying Siow Tan, et al.
Tuberculosis (Edinburgh, Scotland)|January 24, 2015
Increasing the structural coverage of tuberculosis drug targetsLoren Baugh, Isabelle Phan, Darren W Begley, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Cell Chemical Biology|March 2, 2023
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapySimone Bonazzi, Eva d'Hennezel, Rohan E J Beckwith, et al.
Pageof 21